Different members of the PIM family of kinases have been found to be overexpressed in hematological malignancies and solid tumors (reviewed at refs 1, 2, 3, 4), which led to the idea that these proteins could be potentially interesting targets for anticancer drug therapy17, 18, 19, 20. The gene discussed is PIM1; the disease is hematologic disorder.